Page 75 - Schwartz Principios de Cirugía, Capítulo 33 Páncreas

1414 BIBLIOGRAFÍA 23. Kennedy FP. Pathophysiology of pancreatic polypeptide secretion
in human diabetes mellitus. Diabetes Nutr Metab. 1990;2:155.
Las referencias resaltadas en color azul claro son publicaciones importantes. 24. Petrov MS, Shanbhag S, Chakraborty M, Phillips AR, Wind-
1. Silen W. Surgical anatomy of the pancreas. Surg Clin North sor JA. Organ failure and infection of pancreatic necrosis as
Am.1964;44:1253. determinants of mortality in patients with acute pancreatitis.
2. Havel PJ, Taborsky GJ Jr. The contribution of the autonomic ner- Gastroenterology. 2010;139: 813-820.
vous system to changes of glucagon and insulin secretion during 25. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal
hypoglycemic stress. Endocr Rev.1989;10:332-350. disease in the United States: 2012 update. Gastroenterology.
3. Davenport HW: Pancreatic secretion. In Davenport HN, ed: 2012;143(5): 1179-1187.
Physiology of the Digestive Tract, 5th ed. Chicago: Year Book 26. Banks PA. Epidemiology, natural history, and predictors of dis-
Medical Publishers; 1982:143. ease outcome in acute and chronic pancreatitis. Gastrointesinal
4. Valenzuela JE, Weiner K, Saad C. Cholinergic stimulation of Endoscopy. 2002;56(6 Suppl):S226-S230.
human pancreatic secretion. Dig Dis Sci.1986;31:615-619. 27. Akhtar AJ, Shaheen M. Extrapancreatic manifestations of acute
5. Konturek SJ, Becker HD, Thompson JC. Effect of vagot- pancreatitis in African-American and Hispanic patients. Pan-
omy on hormones stimulating pancreatic secretion. Arch creas. 2004; 29(4): 291-297.
Surg.1974;108:704-708. 28. Lowenfels AB, Maisonneuve P. Acute pancreatitis: is smoking a
parTe ii
6. Ebert R, Creutzfeldt W. Gastrointestinal peptides and insulin risk factor for acute pancreatitis. Nat Rev Gastroenterol Hepatol.
secretion. Diabetes Metab Rev. 1987;3:1-26. 2011; 8(11): 603-604.
7. Leahy JL, Bonner-Weir S, Weir GC. Abnormal glucose regula- 29. Acosta JM, Ledesma CL. Gallstone migration as a cause of acute
tion of insulin secretion in models of reduced B-cell mass. Dia- pancreatitis. N Engl J Med. 1974;290:484-487.
betes.1984; 33:667-673. 30. Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute
8. Brunicardi FC, Sun YS, Druck P, et al. Splanchnic neural regula- pancreatitis. N Engl J Med. 1992; 326(9): 589-593.
tion of insulin and glucagon secretion in the isolated perfused 31. Elmunzer BJ,Schelman JM, Lehman GA, et al. A randomized
human pancreas. Am J Surg.1987;153:34-40. trial of rectal indomethacin to prevent post-ERCP pancreati-
9. Yamada Y, Post SR, Wang K, et al. Cloning and functional char- tis. N Engl J Med. 2012; 366:1414-1422.
acterization of a family of human and mouse somatostatin recep- 32. Whitcomb DC. Genetics of alcoholic and nonalcoholic
tors expressed in brain, gastrointestinal tract, and kidney. Proc pancreatitis. Curr Opin Gastroenterol. 2012;28(5):
Natl Acad Sci U S A.1992;89:251-255. 501-506.
10. Voss M, Pappas T. Pancreatic fistula. Curr Treat Options Gastro- 33. Muniraj TT, Aslanian HR. Hypertriglyceridemia independent
enterol. 2002;5:345-353. propofol-induced pancreatitis. J Pancreas. 2012;13: 451-453.
ConsideraCiones espeCífiCas
11. Floyd JC Jr, Fajans SS, Pek S. Regulation in healthy subjects 34. Saluja A, Steer M. Pathophysiology of pancreatitis. Role of
of the secretion of human pancreatic polypeptide, a newly rec- cytokines and other mediators of inflammation. Digestion.
ognized pancreatic islet polypeptide. Trans Assoc Am Physi- 1999;60:27-33.
cians.1976;89:146-158. 35. Hofbauer B, Saluja AK, Lerch MM, et al. Intra-acinar cell activa-
12. Adrian TE, Bloom SR, Besterman HS, et al. Mechanism of pan- tion of trypsinogen during caerulein-induced pancreatitis in rats.
creatic polypeptide release in man. Lancet.1977;1:161-163.
13. Kono T, XP Wang, WE Fisher, DK Andersen, FC Brunicardi. Am J Physiol. 1998;275(2 Pt 1): G352-G362.
Pancreatic Polypeptide (PP). In: L Martini, ed., Encyclopedia of 36. Saluja AK, Lerch MM, Phillips PA, Dudeja V. Why does pan-
Endocrine Diseases Volume 3, Elsevier. 2004; 488-496. creatic overstimulation cause pancreatitis? Annu Rev Physiol.
14. Andersen DK. Mechanisms and emerging treatments of the 2007;69: 249-269.
metabolic complications of chronic pancreatitis. Pancreas. 37. Dawra R, Sah RP, Dudeja V, et al. Intra-acinar trypsinogen activa-
2007;35: 1-5. tion mediates early stages of pancreatic injury but not inflamma-
15. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: tion in mice with acute pancreatitis. Gastroenterol. 2011;141(6):
anovel developmentally regulated islet cell in the human pan- 2210-2217 e2212.
creas. Regul Pept. 2002;107:63-69. 38. Gaiser S, Daniluk J, Liu Y, et al. Intracellular activation of tryp-
16. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, sinogen in transgenic mice induces acute but not chronic pancre-
Sussel L. Ghrelin cells replace insulin-producing beta cells in two atitis. Gut. 2011;60(10): 1379-1388.
mouse models of pancreas development. Proc Natl Acad Sci U S 39. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancre-
A. 2004;101:2924-2429. atitis is caused by a mutation in the cationic trypsinogen gene. Nat
17. Sun Y, Asnicar M, Saha PK, Chan L,Smith RG. Ablation Genet. 1996;14(2): 141-145.
of ghrelin improves the diabetic but not obese phenotype of ob/ob 40. Kloppel G, Dreyer T, Willemer S, et al. Human acute pancreatitis:
mice. Cell Metab. 2006;3:379-386. its pathogenesis in the light of immunocytochemical and ultra-
18. Westermark P, Wilander E, Westermark GT, et al. Islet amyloid structural findings in acinar cells. Virchows Arch A Pathol Anat
polypeptide-like-immunoreactivity in the islet β-cells of type II Histopathol. 1986;409(6): 791-803.
(non-insulin-dependent) diabetic and non-diabetic individuals. 41. Saluja A, Saluja M, Villa A, et al. Pancreatic duct obstruction in
Diabetologia. 1987;30:887-892. rabbits causes digestive zymogen and lysosomal enzyme colocal-
19. Tatemoto K, Efendic S, Mutt V,Makk G, Feistner GJ, Barchas ization. J Clin Invest. 1989;84(4): 1260-1266.
JD. Pancreastatin, a novel pancreatic peptide that inhibits insulin 42. Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, Steer
secretion. Nature. 1986;324:476-478. ML. Experimental pancreatitis is mediated by low-affinity chole-
20. Efendic S, Tatemoto K, Mutt V, Quan C, Chang D, Ostenson CG. cystokinin receptors that inhibit digestive enzyme secretion. Proc
Pancreastatin and islet hormone release. Proc Natl Acad Sci U S Natl Acad Sci. 1989;86(22): 8968-8971.
A. 1987:84:7257-7260. 43. Saluja A, Hashimoto S, Saluja M, et al. Subcellular redistribution
21. Funakoshi A, Miyasaka K, Nakamura R, Kitani K, Tatemoto K. of lysosomal enzymes during caerulein-induced pancreatitis. Am
Inhibitory effect of pancreastatin on pancreatic exocrine secretion J Physiol. 1987;253(4 Pt 1): G508-G516.
in the conscious rat. Reg Peptides. 1989;25:157-166. 44. Van Acker GJ, Saluja AK, Bhagat L, et al. Cathepsin B inhi-
22. Gorelick FS, Jamieson JD. Structure-function relationship of the bition prevents trypsinogen activation and reduces pancreatitis
pancreas. In: Johnson LR, ed: Physiology of the Gastrointestinal severity. Am J Physiol Gastrointest Liver Physiol. 2002;283(3):
Tract. New York: Raven Press; 1981:773. G794-G800.

booksmedicos.org